Tenet Healthcare Corp (THC) stock
THCNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3041% below fair value
$282.07−9.47 (-3.25%)
Close on Nov 17, 2026Market cap $22.45BP/E 8.2Yield –
Tenet Healthcare revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Tenet Healthcare's revenue for the twelve months ending Sep 30, 2026 was $22.15B, up 6.2% year over year. For fiscal 2025 it was $21.31B, up 3.1% from the year before. The highest annual figure on record is $21.31B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.31B | +3.1% |
| FY2024 | Dec 31, 2024 | $20.68B | +0.5% |
| FY2023 | Dec 31, 2023 | $20.56B | +7.2% |
| FY2022 | Dec 31, 2022 | $19.17B | -1.6% |
| FY2021 | Dec 31, 2021 | $19.49B | +10.5% |
| FY2020 | Dec 31, 2020 | $17.64B | -4.5% |
| FY2019 | Dec 31, 2019 | $18.48B | +0.9% |
| FY2018 | Dec 31, 2018 | $18.31B | -4.5% |
| FY2017 | Dec 31, 2017 | $19.18B | -2.3% |
| FY2016 | Dec 31, 2016 | $19.62B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.63B | +6.5% |
| Q2 FY2026 | Jun 30, 2026 | $5.63B | +6.8% |
| Q1 FY2026 | Mar 31, 2026 | $5.37B | +2.8% |
| Q4 FY2025 | Dec 31, 2025 | $5.53B | +8.9% |
| Q3 FY2025 | Sep 30, 2025 | $5.29B | +3.2% |
| Q2 FY2025 | Jun 30, 2025 | $5.27B | +3.2% |
| Q1 FY2025 | Mar 31, 2025 | $5.22B | -2.7% |
| Q4 FY2024 | Dec 31, 2024 | $5.07B | -6.0% |
| Q3 FY2024 | Sep 30, 2024 | $5.13B | +1.2% |
| Q2 FY2024 | Jun 30, 2024 | $5.11B | +0.5% |
| Q1 FY2024 | Mar 31, 2024 | $5.37B | +6.9% |
| Q4 FY2023 | Dec 31, 2023 | $5.40B | +8.1% |
| Q3 FY2023 | Sep 30, 2023 | $5.07B | +5.5% |
| Q2 FY2023 | Jun 30, 2023 | $5.08B | +9.6% |
| Q1 FY2023 | Mar 31, 2023 | $5.02B | +5.8% |
| Q4 FY2022 | Dec 31, 2022 | $4.99B | +2.8% |
| Q3 FY2022 | Sep 30, 2022 | $4.80B | -1.9% |
| Q2 FY2022 | Jun 30, 2022 | $4.64B | -6.4% |
| Q1 FY2022 | Mar 31, 2022 | $4.75B | -0.8% |
| Q4 FY2021 | Dec 31, 2021 | $4.86B | -1.2% |
| Q3 FY2021 | Sep 30, 2021 | $4.89B | +7.4% |
| Q2 FY2021 | Jun 30, 2021 | $4.95B | +35.8% |
| Q1 FY2021 | Mar 31, 2021 | $4.78B | +5.8% |
| Q4 FY2020 | Dec 31, 2020 | $4.92B | +2.3% |
| Q3 FY2020 | Sep 30, 2020 | $4.56B | -0.2% |
| Q2 FY2020 | Jun 30, 2020 | $3.65B | -20.0% |
| Q1 FY2020 | Mar 31, 2020 | $4.52B | -0.6% |
| Q4 FY2019 | Dec 31, 2019 | $4.81B | +4.0% |
| Q3 FY2019 | Sep 30, 2019 | $4.57B | +1.8% |
| Q2 FY2019 | Jun 30, 2019 | $4.56B | +1.2% |
| Q1 FY2019 | Mar 31, 2019 | $4.55B | -3.3% |
| Q4 FY2018 | Dec 31, 2018 | $4.62B | -7.2% |
| Q3 FY2018 | Sep 30, 2018 | $4.49B | -2.1% |
| Q2 FY2018 | Jun 30, 2018 | $4.51B | -6.2% |
| Q1 FY2018 | Mar 31, 2018 | $4.70B | -2.4% |
| Q4 FY2017 | Dec 31, 2017 | $4.98B | – |
| Q3 FY2017 | Sep 30, 2017 | $4.59B | – |
| Q2 FY2017 | Jun 30, 2017 | $4.80B | – |
| Q1 FY2017 | Mar 31, 2017 | $4.81B | – |
See a number that looks wrong?